Maximilian J. Schloss

Maximilian J. Schloss

Auto-generated profile, based on publicly available information

Maximilian J. Schloss

Department of Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2023 in Science
Verified
Journal Article
Closed access
MHMaarten Hulsmans
Maarten Hulsmans
MSMaximilian J. Schloss
Maximilian J. Schloss
ILI-Hsiu Lee
I-Hsiu Lee
ABAneesh Bapat
Aneesh Bapat
YIYoshiko Iwamoto
Yoshiko Iwamoto
MNMatthias Nahrendorf
Matthias Nahrendorf
Atrial fibrillation disrupts contraction of the atria, leading to stroke and heart failure. We deciphered how immune and stromal cells contribute to atrial fibrillation. Single-cell transcriptomes from human atria documented inflammatory monocyte and SPP1 + macrophage expansion in atrial fibrillation. Combining hypertension, obesity, and mitral valve regurgitation (HOMER) in mice elicited enlarged, fibrosed, and fibrillation-prone atria. Single-cell transcriptomes from HOMER mouse atria recapitulated cell composition and transcriptome changes observed in patients. Inhibiting monocyte migration reduced arrhythmia in Ccr2 −∕− HOMER mice. Cell-cell interaction analysis identified SPP1 as a pleiotropic signal that promotes atrial fibrillation through cross-talk with local immune and stromal cells. Deleting Spp1 reduced atrial fibrillation in HOMER mice. These results identify SPP1 + macrophages as targets for immunotherapy in atrial fibrillation.

2 October 2026 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
TNTaylor Nordan
Taylor Nordan
MSMaximilian J. Schloss
Maximilian J. Schloss
NTNaoki Tadokoro
Naoki Tadokoro
MMMandeep Mehra
Mandeep Mehra
MGMichael Givertz
Michael Givertz
AAAkinobu Akinobu
Akinobu Akinobu

19 May 2026 in American Journal of Transplantation
Verified
Journal Article
Closed access
NTNaoki Tadokoro
Naoki Tadokoro
MGMichael M. Givertz
Michael M. Givertz
TNTaylor Nordan
Taylor Nordan
MSMaximilian J. Schloss
Maximilian J. Schloss
VFVanessa S. Faria
Vanessa S. Faria
AAAkinobu Akinobu
Akinobu Akinobu

8 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ZMZoe Möller-Ramon
Zoe Möller-Ramon
AKAnna Christina Kaltenbach
Anna Christina Kaltenbach
SPSarah-Lena Puhl
Sarah-Lena Puhl
IKImmanuel Kwok
Immanuel Kwok
FSFlorian Sicklinger
Florian Sicklinger
JDJohan Duchêne
Johan Duchêne
Myocardial infarction (MI) triggers a systemic neutrophil response, yet the roles of distinct neutrophil subsets in cardiac remodeling remain unclear. Studying this requires murine models that accurately mirror human neutrophil dynamics. Here, we show that a minimally invasive intact-chest MI model is more pathophysiologically relevant than the standard open-chest approach for investigating post-MI immune responses. In the open-chest model, surgical trauma disrupts bone marrow homeostasis, releases large numbers of immature neutrophils, and masks MI-specific immune mechanisms. In contrast, the intact-chest model preserves bone marrow integrity and induces only a modest rise in circulating immature neutrophils, closely reflecting MI patient profiles. We further demonstrate that accumulation of immature neutrophils in the infarcted heart exacerbates cardiac dysfunction. Beyond neutrophils, the overall cardiac immune landscape differs markedly between both models. Collectively, our findings establish the intact-chest model as superior for studying post-MI inflammation and reveal immature neutrophils as mediators of adverse cardiac remodeling.